Douglas A. Treco - Insider Trading & Ownership

Location
87 Cambridgepark Drive, C/O Ra Pharmaceuticals, Inc., Cambridge, MA
Summary
The estimated net worth of Douglas A. Treco is at least $1.29M dollars as of August 8, 2025. Douglas A. Treco is the Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $1.25M. Douglas A. Treco is the CEO & Chairman, Director of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $38.5K.
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Douglas A. Treco

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Director $1.25M +$1.14M +1000% Aug 6, 2025
INZY Inozyme Pharma, Inc. CEO & Chairman, Director $38.5K -$7.85K -16.9% Jul 1, 2025

Insider Transactions Reported by Douglas A. Treco:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.